Last edition
News about "radiopharmaceutical therapies "
Harbour BioMed Signs Strategic Collaboration with Lannacheng on Radionuclide Drug Conjugates
Harbour BioMed has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology to jointly advance the development of next-generation radionuclide drug conjugates, combining both companies’ resources and expertise to accelerate innovation in targeted radiopharmaceutical therapies.
Radiopharmaceutical Therapies | 30/12/2025 | By News Bureau
ARTBIO and Nucleus to Manufacture GMP-Grade Therapeutic Products
ARTBIO, Inc. has announced a strategic manufacturing and supply agreement with Nucleus RadioPharma Inc. to support ARTBIO’s therapeutic product manufacturing.
Radiopharmaceutical Therapies | 08/05/2024 | By Aishwarya | 369
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy